| [1] |
Aydin Buyruk B, Kebapci N, Yorulmaz G, et al. An evaluation of clinicopathological factors effective in the development of central and lateral lymph node metastasis in papillary thyroid cancer[J]. J Natl Med Assoc, 2018, 110(4): 384-390.
|
| [2] |
Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer[J]. JAMA, 2013, 309(14): 1493-1501.
|
| [3] |
Zhang TT, Qi XZ, Chen JP, et al. The association between tumor’s location and cervical lymph nodes metastasis in papillary thyroid cancer[J]. Gland Surg, 2019, 8(5): 557-568.
|
| [4] |
Leboulleux S, Rubino C, Baudin E, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis[J]. J Clin Endocrinol Metab, 2005, 90(10): 5723-5729.
|
| [5] |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J]. Thyroid, 2016, 26(1): 1-133.
|
| [6] |
陈锐, 魏涛, 张明, 等. 甲状腺乳头状癌cN0患者颈侧区淋巴结转移规律的探讨[J]. 中华耳鼻咽喉头颈外科杂志, 2012, 47(8): 662-667.
|
| [7] |
Likhterov I, Reis LL, Urken ML. Central compartment management in patients with papillary thyroid cancer presenting with metastatic disease to the lateral neck: anatomic pathways of lymphatic spread[J]. Head Neck, 2017, 39(5): 853-859.
|
| [8] |
鄢丹桂, 张彬, 安常明, 等. 甲状腺乳头状癌临床N0患者颈部淋巴结转移规律[J] . 中华耳鼻咽喉头颈外科杂志, 2011, 46(11): 887-891.
|
| [9] |
Lei J, Zhong J, Jiang K, et al. Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma[J]. Oncotarget, 2017, 8(16): 27022-27033.
|
| [10] |
Park JH, Lee YS, Kim BW, et al. Skip lateral neck node metastases in papillary thyroid carcinoma[J]. World J Surg, 2012, 36(4): 743-747.
|
| [11] |
Jin WX, Jin YX, Ye DR, et al. Predictive factors of skip metastasis in papillary thyroid cancer[J]. Med Sci Monit, 2018, 24: 2744-2749.
|
| [12] |
Lee YS, Shin SC, Lim YS, et al. Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer[J]. Head Neck, 2014, 36(6): 887-891.
|
| [13] |
Wang W, Gu J, Shang J, et al. Correlation analysis on central lymph node metastasis in 276 patients with cN0 papillary thyroid carcinoma[J]. Int J Clin Exp Pathol, 2013, 6(3): 510-515.
|
| [14] |
Lee YS, Jeong JJ, Nam KH, et al. Papillary carcinoma located in the thyroid isthmus[J]. World J Surg, 2010, 34(1): 36-39.
|
| [15] |
Edge SB, Byrd DR, Comp CC, et al. AJCC Cancer Staging Manual[M]. 8th ed. New York: Springer, 2017.
|
| [16] |
Ito Y, Higashiyama T, Takamura Y, et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection[J]. World J Surg, 2007, 31(11): 2085-2091.
|
| [17] |
Patron V, Hitier M, Bedfert C, et al. Predictive factors for lateral occult lymph node metastasis in papillary thyroid carcinoma[J]. Eur Arch Otorhinolaryngol, 2013, 270(7): 2095-2100.
|
| [18] |
So YK, Kim MJ, Kim S, et al. Lateral lymph node metastasis in papillary thyroid carcinoma: A systematic review and Meta-analysis for prevalence, risk factors, and location[J]. Int J Surg, 2018, 50: 94-103.
|
| [19] |
陈万青, 李贺, 孙可欣, 等. 2014年中国恶性肿瘤发病和死亡分析[J]. 中华肿瘤杂志, 2018, 40(1): 5-13.
|
| [20] |
Kim SK, Park I, Woo JW, et al. Predictive factors for lymph node metastasis in papillary thyroid microcarcinoma[J]. Ann Surg Oncol, 2016, 23(9): 2866-2873.
|
| [21] |
Zhao W, Chen S, Hou X, et al. Predictive factors of lateral lymph node metastasis in papillary thyroid microcarcinoma[J]. Pathol Oncol Res, 2019, 25(3): 1245-1251.
|
| [22] |
Ryu YJ, Kang SJ, Cho JS, et al. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer[J]. Medicine (Baltimore), 2018, 97(51): e13435.
|
| [23] |
孟庆东. 多灶性甲状腺乳头状癌的临床特征及淋巴结转移因素分析[D]. 长春：吉林大学, 2018.
|
| [24] |
孟庆东, 边学海, 孙辉, 等. 多灶性甲状腺乳头状癌的诊疗进展[J]. 中国普通外科杂志, 2016, 25(11): 1640-1645.
|
| [25] |
王刚平, 张红, 武杰, 等. 多灶性甲状腺乳头状癌生物学行为分析[J]. 山东医药, 2011, 51(29): 72-73.
|
| [26] |
殷德涛, 韩飏, 张亚原, 等. 多灶性甲状腺乳头状癌的临床病理及颈淋巴结转移特征[J]. 中国普通外科杂志, 2017, 26(5): 556-560.
|
| [27] |
Wang W, Su X, He K, et al. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2 000 consecutive patients[J]. Cancer, 2016, 122(2): 198-206.
|
| [28] |
王伟斌, 苏星韵, 阮佳莹, 等. 2 682例甲状腺乳头状癌临床病理及预后分析[J]. 中华普通外科杂志, 2018, 33(5): 393-397.
|
| [29] |
赵敬柱. 甲状腺乳头状癌侧颈淋巴结转移的危险因素分析[C]//中国抗癌协会甲状腺癌专业委员会，中国抗癌协会头颈肿瘤专业委员会，中华医学会肿瘤分会头颈学组. 2014第六届全国甲状腺肿瘤学术大会论文集.天津，2014: 340-346.
|
| [30] |
Zeng RC, Zhang W, Gao EL, et al. Number of central lymph node metastasis for predicting lateral lymph node metastasis in papillary thyroid microcarcinoma[J]. Head Neck, 2014, 36(1): 101-106.
|